BioSpace News Archive

Cara Therapeutics, Inc. today announced the Company will host a conference call and live audio webcast on Monday, August 7, 2023, at 4:30 p.m. ET to report second quarter 2023 financial results and provide a corporate update.

Immatics N.V. today announced that Bristol Myers Squibb (NYSE: BMY) has made a $35 million equity investment in Immatics.

Tango Therapeutics, Inc. today announced that the first patient has been dosed in the phase 1/2 trial evaluating TNG260 in combination with pembrolizumab in patients with STK11-mutant cancers.

FibroGen, Inc. (NASDAQ: FGEN) will announce its second quarter 2023 financial results on Monday, August 7 after the market close.

Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced the appointment of Linda C. Burkly, Ph.D., as the Company’s Executive Vice President and Chief Scientific Officer.

Cabaletta Bio, Inc. today announced the appointment of Shawn Tomasello to its Board of Directors.

Inspire Medical Systems, Inc. today announced the appointment of Carlton Weatherby as Chief Strategy Officer, effective July 24, 2023.

Almirall, S.A., the global biopharmaceutical company based in Barcelona, has announced its H1 2023 financial results.

Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd., a global leader in generic and innovative medicines and Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced that they have agreed to expand their existing strategic partnership agreement.

Allarity Therapeutics, Inc. announced the appointment of three seasoned biotechnology executives, Laura Benjamin, Ph.D., Robert Oliver, M.B.A., Joseph Vazzano, C.P.A., to its Board of Directors, effective August 1, 2023.